Wednesday, 22 November 2017
Like generics 10 yrs ago, expect a biosimilar cliff by 2020-2022: Vinay Khattar, Edelweiss Financial Services
Once a biosimilar cliff happens, how many companies in India would be able to play that is going to be of interest. At this point in time, it does not seem to be a very broad-based bouquet of companies which we can bet on.
You can read more here: Like generics 10 yrs ago, expect a biosimilar cliff by 2020-2022: Vinay Khattar, Edelweiss Financial Services
Subscribe to:
Post Comments (Atom)
Life insurers earn more in Oct selling lesser policies
The 24-company Indian life insurance industry closed last month with new business of Rs 22,776.03 crore, up by 31.87 per cent over the prev...
No comments:
Post a Comment